Literature DB >> 15752928

The prevention of type 2 diabetes mellitus.

Silvio E Inzucchi1, Robert S Sherwin.   

Abstract

With a worldwide pandemic of type 2 diabetes upon us, it is imperative that effective and practical preventive strategies be developed for this disease which, once established, carries with it excess morbidity and mortality. This article reviews recently published data on the prevention of type 2 diabetes and compares the demonstrated effectiveness of each strategy, including lifestyle modification and several pharmacologic agents. Although much new information is available, many translational questions remain that chiefly concern the generalizability and applicability of these programs to clinical practice. Recent diabetes prevention guidelines are discussed, and a practical framework for their implementation is presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752928     DOI: 10.1016/j.ecl.2004.11.008

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  16 in total

Review 1.  The role of incretin therapy at different stages of diabetes.

Authors:  Simona Cernea
Journal:  Rev Diabet Stud       Date:  2011-11-10

2.  Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.

Authors:  Tine E Thingholm; Steffen Bak; Henning Beck-Nielsen; Ole N Jensen; Michael Gaster
Journal:  Mol Cell Proteomics       Date:  2011-06-22       Impact factor: 5.911

3.  ATP6V1H facilitates osteogenic differentiation in MC3T3-E1 cells via Akt/GSK3β signaling pathway.

Authors:  Fusong Jiang; Haojie Shan; Chenhao Pan; Zubin Zhou; Keze Cui; Yuanliang Chen; Haibo Zhong; Zhibin Lin; Nan Wang; Liang Yan; Xiaowei Yu
Journal:  Organogenesis       Date:  2019-07-04       Impact factor: 2.500

4.  Molecular modeling of lanthionine synthetase component C-like protein 2: a potential target for the discovery of novel type 2 diabetes prophylactics and therapeutics.

Authors:  Pinyi Lu; David R Bevan; Stephanie N Lewis; Raquel Hontecillas; Josep Bassaganya-Riera
Journal:  J Mol Model       Date:  2010-05-30       Impact factor: 1.810

5.  Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.

Authors:  Silvio E Inzucchi; Catherine M Viscoli; Lawrence H Young; Karen L Furie; Mark Gorman; Anne M Lovejoy; Samuel Dagogo-Jack; Faramarz Ismail-Beigi; Mary T Korytkowski; Richard E Pratley; Gregory G Schwartz; Walter N Kernan
Journal:  Diabetes Care       Date:  2016-07-27       Impact factor: 19.112

6.  Type 2 diabetes risk forecasting from EMR data using machine learning.

Authors:  Subramani Mani; Yukun Chen; Tom Elasy; Warren Clayton; Joshua Denny
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

7.  In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.

Authors:  Kuan-Chun Chen; Wei-Hsian Yin; Chih-Cheng Wu; Shih-Hung Chan; Yen-Wen Wu; Kuo Yang Wang; Kuan-Cheng Chang; Juey-Jen Hwang; Wen-Chol Voon; I-Chang Hsieh; Jun-Ted Chong; Wei-Shiang Lin; Chih-Neng Hsu; Kwo-Chang Ueng; Chih-Ping Hsia; Ju-Chi Liu; Jong-Shiuan Yeh; Guang-Yuan Mar; Jhih-Yuan Shih; Jen-Yuan Kuo; Hsuan-Ming Tsao; Wei-Kung Tseng; Cheng-Hsu Yang; Chao-Chien Chang; Chern-En Chiang; Meng-Heng Lei; Jeng-Feng Lin; Kou-Gi Shyu
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

Review 8.  A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease.

Authors:  Enrique Z Fisman; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2009-07-20       Impact factor: 9.951

9.  First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.

Authors:  Yu Jie Chen; Liang Jin Li; Wen Lu Tang; Jia Yang Song; Ru Qiu; Qian Li; Hao Xue; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2018-11-14

10.  Effects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: a factorial clinical trial.

Authors:  Hamdee Attallah; Anne L Friedlander; Matilde Nino-Murcia; Andrew R Hoffman
Journal:  PLoS Clin Trials       Date:  2007-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.